Loading Image
Header with Sliding Bar
Hero Image

Human Practices

Content Corner Image

Overview

The first step of iGEM Human Practices is reflection, which involves considering the driving values behind the project and designing a meaningful Human Practices plan. At the beginning of our project, our team identified the issue we aim to address with VersaTobacco: the conflict between the high value and demand for plant natural products and the difficulty in obtaining them in large quantities.

Plant natural products have significant application value in medicine and chemical engineering. However, these molecules sometimes exist in complex mixtures or are produced in a limited number of cell types, which reduces their accessibility. Furthermore, complex stereochemistry can limit the feasibility of chemical synthesis. By optimizing the metabolic network of Nicotiana benthamiana, we hope to develop a universal plant chassis capable of heterologously producing specific plant natural products in a short time.

We brainstormed a list of driving questions that we wanted to address throughout our Human Practices journey:

Our Human Practices (HP) journey will focus on addressing the above questions. We hope that through our HP work, we can find answers to these questions and provide insights for future iGEM teams using gene editing technology for plant synthetic biology research.

See Education

This year, our integrated Human Practices began by gathering public opinions to understand public awareness and concerns regarding plant synthetic biology and its products. Guided by this, we communicated closely with stakeholders from academia and industry at every project stage. By integrating diverse perspectives, we aim to develop VersaTobacco into a platform that is academically recognized, needed by the industry, and trusted by the public for its efficiency and safety.

In these sentences, SCU-China recorded its beautiful expectations, love for plant synthetic biology, and sense of responsibility, reflecting rigorous and innovative synthetic biology thinking. Here, we thank everyone who has helped make VersaTobacco better.

Filter By:

Gathering Public Opinion

At the beginning of our project design, we surveyed the public's understanding of plant synthetic biology and their acceptance of its products, aiming to gauge their knowledge, attitudes, and concerns.

Fig.1 Survey on the public's understanding of plant synthetic biology and product acceptance

Over one month, we received 312 valid responses. We analyzed the responses from the following three aspects:

1.The public's understanding of plant synthetic biology

35.51% of respondents had never heard of "plant synthetic biology," 39.88% had heard of it but were unfamiliar with it, 17.76% had some knowledge, and 6.85% were very knowledgeable. It shows that most people have little or no understanding of "plant synthetic biology." We should carry out related science popularization activities to raise public awareness, increase its visibility, and enhance understanding.

Regarding the application fields of plant synthetic biology, agriculture was considered the most useful, with 93.77% of respondents selecting it. It indicates that people generally believe plant synthetic biology can help improve crop yields and disease resistance, positively impacting agriculture.

The second most recognized field was healthcare, accounting for 82.87%. It shows that people are optimistic about the potential of plant synthetic biology in drug production, expecting it to bring innovation and improvements to the medical industry.

2.The public's attitudes toward plant synthetic biology products

When asked whether they support the continued research and development of plant synthetic biology technologies for producing natural metabolites, most respondents (60.75%) highly supported further research and development. 31.15% were likely to support it. Only a small number of respondents expressed uncertainty (6.85%), possible opposition (0.62%), or complete opposition (0.62%).

More than 80% of respondents indicated they would likely or be willing to purchase medicines, essential oils, or fragrances produced using plant synthetic biology technology. Fewer than 4% of respondents said they would likely not purchase such products. Meanwhile, 14.95% of respondents were uncertain, suggesting that further information or education may be needed to increase their trust. During commercialization, it will be essential to provide more information about plant synthetic biology technologies, such as their benefits, safety, and environmental friendliness, to improve the acceptance rate among the uncertain group.

3.The issues the public concerned about regarding such products

Several factors influence the public's acceptance of plant natural metabolites produced by synthetic biology, with health and safety being the most significant, accounting for 83.49%. It indicates that people prioritize health and safety when choosing products. Product price is another factor, with 51.71% of respondents listing it as a consideration. It suggests that competitive pricing is also essential when promoting plant natural metabolites produced through synthetic biology.

Project Initial Design

In this section, we had multiple discussions with Dr. Yang Zhang and Dr. Rao Fu from Sichuan University College of Life Sciences. Ultimately, we confirmed the plans for the target metabolic pathway, knockout methods, and chassis function validation methods.

Joan Miguel Romero

Dr. Yang Zhang

Dr. Zhang's laboratory has long been dedicated to the study of plant secondary metabolism, focusing primarily on the following areas:

  • the synthesis and regulation of plant secondary metabolism in model plants
  • the biosynthesis and regulation of critical medicinal molecules in medicinal plants
  • secondary metabolic engineering of important plant natural products
Joan Miguel Romero

Dr. Rao Fu

Dr. Fu has long been engaged in fundamental scientific research and applied development related to plant natural products. He is currently focusing on elucidating biosynthetic pathways for natural products and identifying novel and unique enzymes involved in these pathways.

First meeting: Selection of target metabolic pathways

Initially, we conducted untargeted metabolomic analysis on N. benthamiana to identify target metabolic pathways worth modifying. Since the genome of N. benthamiana was only published in 2023 and the metabolomic data has yet to be publicly available, we could not clearly define modification targets based on existing database data. Therefore, the focus of the first meeting was primarily on selecting metabolic pathways.

Dr. Zhang believes that the key to engineering a plant chassis for heterologous production of plant natural metabolites is optimizing and redistributing the metabolic network of N. benthamiana. This involves reducing the levels of specific metabolites in N. benthamiana, and redirecting the substrates and energy originally used for their synthesis towards heterologous synthesis. The target metabolites should possess the following characteristics:

  • They are present in high concentrations in tobacco.
  • Their reduction does not affect average plant growth.
  • Their substrates can produce various metabolites through the catalysis of different enzymes.

Dr. Fu proposed that the metabolites in Nicotiana benthamiana most suitable for knockout targets are primarily alkaloids and chlorogenic acid. Both classes of compounds are characterized by their high concentration and the ability to be reduced to levels that do not affect growth. Additionally, their substrates are located in the middle of the metabolic flux, so reducing their levels can significantly alter the distribution of metabolic flow.

Subsequently, through literature review, we found that a low-nicotine chassis has already been constructed[1], while a low-chlorogenic acid chassis has not yet been studied. From an innovative perspective, we ultimately selected chlorogenic acid as our knockout target.

Question:Chlorogenic acid itself is a compound with significant medicinal value. Why is it recommended as a knockout target?

Dr.Fu:We aim to develop a universal plant chassis for heterologous production of other high-value medicinal compounds. By transiently expressing the critical genes involved in the synthesis of various compounds, VersaTobacco can produce different compounds in a short period of time. From this perspective, chlorogenic acid is not our production target. Moreover, as one of the main metabolites in N. benthamiana, it competes with the metabolic flux in the target pathway and is, therefore an unnecessary component.

Second meeting: Selection of target gene for knockout

The synthesis of chlorogenic acid in tobacco involves a multi-step enzyme-catalyzed reaction. Which key enzyme should be knocked out to reduce the production of chlorogenic acid while not affecting average plant growth? To address this issue, Dr. Zhang suggested that we conduct a modelling analysis of the metabolic flux related to chlorogenic acid in tobacco.

Unlike microorganisms, the metabolites and metabolic fluxes in plants vary significantly across different periods and organs. Dr. Zhang recommended that we analyze the N. benthamiana genome published by others in conjunction with KEGG and GO analyses. Dr. Zhang's laboratory also provided us with some metabolomic data for the wild-type N.benthamiana LAB strain.

Combining this data, we performed COBRA metabolic flux analysis on Nicotiana benthamiana and target NbHQT for knockout.

Third meeting: Methods for verifying chassis functionality

We anticipate that in a low-chlorogenic acid chassis, the levels of chlorogenic acid and its derivatives will significantly decrease while the metabolic fluxes of other pathways will increase. Verifying this aspect is a critical issue we need to address. Because chlorogenic acid metabolism falls under the shikimic acid pathway, we decided to heterologously synthesize a specific high-value compound absent in N. benthamiana in both the knockout mutants and the wild type and compare their synthesis yields. If the mutant shows a higher yield, it would strongly demonstrate the value of the chassis. Dr. Zhang confirmed the validity of our approach.

Additionally, he suggested that, apart from selecting compounds from the shikimic acid pathway as validation products, we should also choose synthetic products from the MEP and MVA pathways for comprehensive verification.

Dr. Fu provided suggestions from the substrate perspective regarding the selection of alternative synthetic products. p-Coumaryl-CoA is an essential substrate for synthesizing flavonoids and stilbenes and is located upstream of the shikimic acid metabolic pathway. Meanwhile, caffeoyl-CoA is a direct substrate for chlorogenic acid synthesis. He recommended that we select two target synthetic products from the shikimic acid pathway, one using p-Coumaryl-CoA and the other using caffeoyl-CoA as reaction substrates so that we can simultaneously assess the heterologous synthesis efficiency of the new chassis at two metabolic levels.

After considering the opinions of both professors and engaging in multiple discussions with them, we ultimately selected phaselic acid and resveratrol from the shikimic acid pathway and crocin from the MEP pathway as our validation products.

Project Refinement

Chlorogenic acid: knock out or knock down?

Joan Miguel Romero

Prof. Yongfeng Guo

Prof. Yongfeng Guo is currently the head of the Laboratory of Plant Developmental Molecular Biology at the Tobacco Research Institute of the Chinese Academy of Agricultural Sciences, deputy director of the Biotechnology Research Center, and chief scientist of the Tobacco Functional Genomics Innovation Team.

We consulted Prof. Guo on whether knocking out the HQT in the chlorogenic acid synthesis pathway would increase the yield of target metabolites and whether further knockouts or suppression of other competing pathways would be necessary. Prof. Guo suggested that completely knocking out NbHQT might have potential adverse effects on development (including stress-related development). Even with a total knockout of NbHQT, various external factors could still influence plant growth, making the outcome uncertain. Therefore, he recommended conducting preliminary experiments with varying degrees of gene knockout to evaluate the effects of each factor, aiming to find the optimal solution that balances chassis stability with risk management.

Considering the long-term nature of plant tissue culture and the technical complexity of simultaneously knocking out multiple genes, we decided to construct single knockout vectors for NbHQT1, NbHQT2, NbHQT3, and NbHQT4, as well as double knockout vectors for NbHQT1+3 and NbHQT2+4.

Heterologous synthesis of phaselic acid

Joan Miguel Romero

Prof. Qipeng Yuan

Prof. Qipeng Yuan, a leading academic in natural medicinal sciences and engineering at Beijing University of Chemical Technology, focuses on isolating natural active ingredients, biosynthesis, and synthetic biology. We had an in-depth discussion with Prof. Yuan regarding the synthetic pathways' design and optimisation for our project's three verification products.

In this project, we exogenously introduced the HCT-M into the HQT gene-partially-knocked-out mutant tobacco, allowing the mutant tobacco to synthesize phaselic acid by reacting the endogenously produced caffeoyl-CoA with malic acid. Since malic acid is an essential component of the TCA cycle, we were uncertain whether to supplement the reaction with exogenous malic acid as a substrate. Prof. Yuan suggested directly using the malic acid from the endogenous TCA cycle. He noted that intracellular malic acid levels are typically high, so there is no need to worry about whether the accumulation is sufficient. Furthermore, even if the amount was the overexpression of PDC enzyme could directly convert phosphoenolpyruvate (PEP) into oxaloacetate, which can then be reduced to produce malic acid.

In subsequent experiments, we used endogenous malic acid as the substrate, and indeed, a significant amount of phaselic acid was successfully synthesized.

Heterologous synthesis of crocin

Upon reviewing the literature, we found that the yield of crocin in N. benthamiana is relatively low. We wanted to explore whether modifying glycosyltransferases could enhance the water solubility of crocin and whether this would significantly impact the quality and efficacy of the product. Prof. Qipeng Yuan believes that adding glycosyl groups would indeed increase water solubility, promote the production of the final product, and reduce both the impact on cell membranes and toxicity, making it a promising approach.

At the same time, Prof. Yongfeng Guo emphasized that glycosylation is crucial. There are many types of modifications, and for some proteins or product complexes, glycosylation can significantly alter the activity of the compounds. Therefore, experiments or machine learning predictions would be necessary to evaluate the impact of glycosylation on product efficacy.

Enzyme design

Joan Miguel Romero

Dr. Xiaolin Shen

Dr. Xiaolin Shen from Beijing University of Chemical Technology focuses on the biosynthesis and metabolic regulation of natural active ingredients in Escherichia coli and yeast, as well as enzyme engineering.

Upon reviewing the literature, we found that HCT-M can bind to multiple substrates, leading to various side reactions, such as the formation of coumaroyl malate from coumaroyl-CoA and malate or the production of feruloyl-CoA from feruloyl-CoA and malate. Notably, the \(V_{max}/K_m\) ratios for these reactions can be higher than that of the reaction producing phaselic acid. To improve enzyme specificity, Dr. Shen emphasized that modifications should be made to improve its selectivity through methods such as protein engineering, rational design, and semi-rational design. He suggested identifying the reasons for the enzyme's lack of specificity and exploring similar causes using AlphaFold.

Considering the laboratory conditions and project timeline, Dr. Shen recommended adopting a semi-rational design approach. He noted that implementing directed evolution would entail a considerable workload, and due to time constraints, this may not be feasible.

Regarding the enhancement of resveratrol production, Dr. Shen also suggested employing semi-rational design to improve yield. Following his advice, we proceeded to utilize molecular docking and kinetic simulation methods to perform semi-rational design on the two enzymes. We screened the mutants based on Gibbs free energy and hydrogen bond formation to enhance the success rate of the mutations.

Modeling Validation

After obtaining the initial modelling results, we discussed the modeling methods with Prof. Guo. At that time, we did not have metabolic profiling data from the knockout mutants, so Professor Guo suggested incorporating a representative compound from the tobacco metabolic flow, such as nicotine, into our metabolic model for validation. However, our designed COBRA (Constraint-Based Reconstruction and Analysis) metabolic flow analysis model for N.benthamiana essentially functions as a type of linear programming tool. Due to the minimal crossover between the nicotine pathway and the caffeic acid pathway in the metabolic network and in the absence of prior constraints and experimental data, the modelling results for the two pathways generated significant conflicts. Therefore, we ultimately selected the caffeic acid pathway as the primary focus for our metabolic flow analysis model.

Experimentations

Plasmid Construction

Joan Miguel Romero

Yuze Li

Yuze Li is a PhD candidate from Dr. Zhang's lab and is engaged in the metabolic profiling analysis of N.benthamiana. He provided us with the gene sequences for the four NbHQTs and offered protocols for each CRISPR plasmid construction process step, including selecting sgRNA, linking sgRNA to the plasmid, and designing relevant primers, with Yuze Li guiding us through each stage.

When constructing the CR-nbhqt1 and CR-nbhqt1+3 knockout mutant plants, we consistently failed to obtain resistant shoots for these two types of plants. Yuze Li suggested that NbHQT1 is primarily expressed in the roots, which may be crucial for the early growth of tobacco plants; therefore, knocking out NbHQT1 could hinder proper shoot differentiation. He recommended that we focus more on knocking out NbHQT2 and NbHQT4, which have higher expression levels in the leaves.

In addition, Yuze Li generously served as a consultant for our wet lab work, and we maintained regular communication with him throughout the experimental process.

Joan Miguel Romero

Yuting Xiang

Under Dr. Zhang's suggestion, we decided to use Gateway cloning to construct expression vectors for the three validation products. Yuting Xiang is a PhD candidate in Dr. Zhang's lab. She provided us with the relevant plasmids and detailed protocols and assisted us in analyzing the reasons for our experimental failures. Regarding the ALDH expression plasmid that we had struggled to construct, she recommended that we abandon the Gateway method and try using Gibson assembly instead.

Metabolite Extraction and Detection

Joan Miguel Romero

Dr. Xihua Wang

Dr. Xihua Wang from the Mass Spectrometry Platform at Sichuan University's School of Life Sciences designed a gradient elution program and mass spectrometry parameters for the non-targeted metabolomics analysis of tobacco in negative ion mode, as well as for the detection of carotenoid content in tobacco leaves. During the experiment, Dr. Wang communicated with us regarding the validity and reproducibility of the experimental data and assisted with data analysis.

Joan Miguel Romero

Yuze Li

Yuze Li provided us with the protocol for metabolite extraction and conducted training sessions on related experiments. During the data analysis phase, he taught us methods for annotating and quantifying non-targeted metabolomics data.

Implementation

Exploration of Application Models

Joan Miguel Romero

Prof. Yongfeng Guo

To enable VersaTobacco to produce large-scale plant natural metabolites, we must overcome significant challenges, including mass cultivation, infiltration, and plant sampling.

We learned from Prof. Yongfeng Guo that Agrobacterium is injected using a syringe for transient transformation in ordinary biological laboratories. There are successful cases of industrialized transient expression abroad. For example, Medicago's COVID-19 vaccine utilized transient expression in N. benthamiana.

Professor Guo mentioned that in China, the regulation of genetically modified organisms primarily focuses on field planting. For production materials, soilless cultivation in laboratory-scale factories offers more uniformity between batches and individuals, which is beneficial for ensuring the stability of the final product. Additionally, large-scale production cannot rely on syringe injection for Agrobacterium infiltration. A standard factory method uses vacuum pressure to draw the Agrobacterium suspension into the intercellular spaces. This method is very effective for N. benthamiana, as its tissues are relatively loose but much more costly than field planting.

If we can construct highly effective tobacco materials that produce valuable compounds, Professor Guo suggested collaborating with enterprises or applying for patents to facilitate the transformation of our results. However, this would undoubtedly present significant challenges.Based on Professor Guo's description, we researched similar application precedents[2, 3] and initially determined our application model.

We aim to cultivate a large quantity of N. benthamiana using artificially lit and temperature-controlled growth facilities, utilizing soilless media. By exploring suitable fermentation protocols in industrial fermenters, we intend to produce large quantities for injection into Agrobacterium. The N. benthamiana plants used for infiltration experiments were grown for 5 weeks. For infiltration, we placed the flowerpots in a small basin with a barrier and inverted the small basin into the Agrobacterium suspension. In this case, the fixed flowerpots were inverted into a stainless steel tank, allowing all N. benthamiana leaves to be immersed in a suspension of A. tumefaciens. Then, agroinfiltration was carried out using a vacuum infiltration device. Upon starting the device, the vacuum chamber's pressure dropped to a particular value, drawing out the air from the intercellular spaces and allowing the suspension to enter the leaf cells. Finally, the plants were cultured in a dark chamber for 24 hours before being returned to the greenhouse for another 4 days until they were ready to be harvested. The infiltrated leaves were then subjected to the subsequent extraction, purification, and analysis steps(Fig.2).


Fig.2 A diagram of the large-scale production process of VersaTobacco in industrial applications

Cost and Risk Assessment

Fig.3 SCU-China team members meeting with Mr.Xie from Aktin Chemicals, Inc.

To understand the industry perspective, we had a meeting with Mr. Xie, Chairman of Aktin Chemicals, Inc. Aktin Chemicals, Inc. is dedicated to improving people's lives by developing and manufacturing quality bioactive ingredients and molecules, as well as providing CMO/CDMO solutions for global nutraceutical, cosmetic, and pharmaceutical industries.

He acknowledged the scientific significance of our project but expressed concerns about its commercial value. He pointed out that for our project to achieve industrialization, we need to overcome at least four cost issues: the cost of N. benthamiana, the cost of fermentation, the cost of the infiltration process, and the cost of product extraction. Firstly, it is crucial to significantly reduce the cost of industrial transformation, ideally achieving high yields with a single spray. Secondly, we need to lower the cultivation costs of N. benthamiana (such as greenhouse cultivation costs). Furthermore, the yield of the products in N. benthamiana must be increased to at least 10% of the total fresh weight for companies to justify mass production.

Regarding selecting target products for production, he mentioned that resveratrol and crocin could serve as chassis validation products. However, the target products for commercial production must consider market demand and optimal methods. He also highlighted the importance of innovation at the gene-editing level, indicating that the core work should focus on gene design and improvement before returning to the downstream experimental components to mitigate risks.

Afterward, we gathered the relevant data from Aktin Chemicals, Inc for commercial modelling. For related results, please refer to the Market Promising Analysis

Biosafety

Fig.4 SCU-China team members meeting with Mr.Zhang from Aktin Chemicals, Inc.

Lin Zhang: the Technical Director of Plant Extraction and Purification at Gentton, provided valuable advice from an industrial perspective regarding the safety of our project design and its future applications.


Prevention of Agrobacterium and plasmid residues

Mr. Zhang emphasized that since we are using Agrobacterium for transformation, we need to pay attention to potential residues of bacterial liquid and plasmid in the leaves. He identified several factors to avoid such residues:

  • Bacterial strain toxicity: Given that we are using the commercial Agrobacterium strain GV3101, the strain poses minimal risk.
  • Plant washing: After sampling, the leaves can be washed multiple times to remove surface Agrobacterium, reducing the amount that may enter during subsequent extraction processes.

Upon learning that we will still need to conduct plant and product purification after leaf sampling, Mr. Zhang stated that it is possible to almost completely avoid any residues with a well-designed extraction process. During metabolite extraction and purification, various organic solvents are used, and multiple chromatographic techniques (such as affinity chromatography, ion exchange chromatography, and gel filtration) are employed. These not only enhance purity but also effectively remove Agrobacterium and vector residues.

However, the actual procedures and regulatory standards to be followed depend on specific circumstances and requirements. According to the Guidelines for the Safety Evaluation of Gene-Edited Plants for Agricultural Use (Trial) issued by China's Ministry of Agriculture and Rural Affairs, a comprehensive evaluation of the absence of Agrobacterium and plasmid residues, requires analyzing residual vector sequences, including analyzing the backbone sequence, main components, and providing details on test methods, data quality, analysis methods, and conclusions. Additionally, assessing and providing evidence for the gene-editing off-target effects is essential.

Prevention of the release of gene-edited plant seeds into the natural environment

After using CRISPR/Cas9 to knock down chlorogenic acid levels, it is theoretically expected that lignin will accumulate, leading to higher biomass accumulation in the gene-edited plants compared to wild types. Although the target gene knockout does not confer any genetic preference or ecological niche advantage, passing environmental and food safety assessments will require adhering to the guidelines set by the Ministry of Agriculture and Rural Affairs of China in the Safety Evaluation Guidelines for Gene-Edited Plants for Agricultural Use (Trial). These guidelines mandate the assessment of the target traits across different generations, requiring at least three generations of experimental data. If the target traits do not increase environmental safety risks, data or analysis proving this must be provided. Similarly, if the traits do not increase food safety risks, corresponding data or analysis should be submitted. Following this, further trials, including intermediary tests, are necessary, with a comprehensive experimental report to be provided.

All these evaluations are contingent on the success of initial lab tests. Lab test success criteria include the following:

  1. Stable yields and reliable product quality;
  2. Defined operational conditions, and established analysis methods for products, intermediates, and raw materials;
  3. Corrosion resistance tests on specific equipment and pipelines have been conducted, and the necessary general equipment is available;
  4. A material balance has been performed, and preliminary methods for handling industrial "three wastes" (waste gas, wastewater, and solid waste) have been proposed;
  5. Specifications and consumption levels of raw materials have been established;
  6. Safety production requirements have been outlined.

We have considered the above aspects to the best of our ability. Regarding point 2, we have established analysis methods for the raw materials in the wet laboratory section. For point 4, since we are developing a universal chassis with various target compounds, we cannot determine specific analysis methods. However, we consulted Mr. Zhang about the general framework for the analysis methods, which primarily involved solvent extraction and macroporous resin separation. After separation, recovery is performed, and crystallization methods are designed based on the solvent properties (this involves experimenting with different solvents and reviewing relevant literature to design experiments). The general process cycle takes approximately 5 to 7 days. Concerning waste management, Mr. Zhang indicated that once the extraction method is finalized, waste handling can be coordinated with specialized companies authorized by the government to design the collection, transportation, and treatment methods for the waste liquids.

For point 5, using the production of resveratrol from VersaTobacco as an example, we obtained relevant production data from Mr. Xie, Chairman of Aktin Chemicals, Inc. We conducted a preliminary material balance and performed an ROI Analysis and Risk-Return Analysis in the modelling section.

Future Possibilities

During our discussions, stakeholders presented us with many brilliant ideas to help explore further possibilities for VersaTobacco. Unfortunately, we cannot complete this during the current season due to time constraints. We have compiled the experts' suggestions here to provide iGEM teams with different perspectives for consideration.

Joan Miguel Romero

Dr. Jinquan Huang

Dr. Huang is a researcher at the Center for Excellence in Molecular Plant Sciences, Chinese Academy of Sciences, focusing on the extracellular biosynthesis and regulation of plant natural products. He provided several improvement strategies for enhancing plant metabolite yields from various angles, including vector construction and plant biomass.

While the transient transformation of N. benthamiana allows each gene to be placed on different plasmids, mixing and injecting Agrobacterium containing different plasmids does not guarantee that all genes will be introduced into the same cell. Some cells within a leaf may receive all genes, while others may only receive one. This discrepancy could significantly affect production efficiency. Dr. Huang suggested we add linkers between gene sequences to express the genes in a polycistronic format.

The advantage of N. benthamiana lies in its ability to produce target metabolites within 1 to 2 weeks through transient transformation; however, its biomass is significantly smaller than that of conventional tobacco. Dr. Huang recommended that we find ways to increase the biomass of N. benthamiana, potentially through hormone application or further modification of the chassis.

To enhance the content of a specific class of compounds, we could consider overexpressing related transcription factors. For instance, if we aim to increase flavonoid content, we could explore introducing AtMYB12 into tobacco[4].

In the End

As we stand on the precipice of a new era in plant synthetic biology, the possibilities are as boundless as the metabolic pathways we seek to reengineer. The insights garnered from the expert consultations and the strategic experiments conducted during this project have propelled our understanding of VersaTobacco's potential and laid the groundwork for a transformative approach to plant-based production systems.

Looking ahead, integrating advanced genetic manipulation techniques with the nuanced understanding of plant metabolism presents a paradigm where the traditional barriers of scalability and efficiency are no longer insurmountable. Pursuing a universal plant chassis is not merely a scientific endeavor but a commitment to a future where the convergence of biology, technology, and sustainability reshapes our capacity to address global challenges.

References

[1] Vollheyde, K., et al., An improved Nicotiana benthamiana bioproduction chassis provides novel insights into nicotine biosynthesis. New Phytologist, 2023. 240(1): p. 302-317.

[2] Golubova, D., et al., Engineering Nicotiana benthamiana as a platform for natural product biosynthesis. Current Opinion in Plant Biology, 2024. 81: p. 102611.

[3] Yao, X., et al., Engineering the expression of plant secondary metabolites-genistein and scutellarin through an efficient transient production platform in Nicotiana benthamiana L. Front Plant Sci, 2022. 13: p. 994792.

[4] Wang, F., et al., AtMYB12 regulates flavonoids accumulation and abiotic stress tolerance in transgenic Arabidopsis thaliana. Mol Genet Genomics, 2016. 291(4): p. 1545-59.

Footer